drugset / Trial / NCT06088017

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

NCT06088017

Phase 1 Completed 66 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-391(2)

Timeline

Start
2023-10-23
Primary completion
2024-01-07
Completion
2024-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-331 Unknown Oral
Subject CKD-391(2) Unknown Oral
Subject D337 Unknown Oral

Indications